A tissue bank is an establishment that fetches and recovers human cadaver tissue for medical research, education, and allograft transplantation. A tissue bank may also belong to a place where biomedical tissue is stored under cryogenic conditions and is generally used more clinically. The common tissue types found in tissue banking are bones, ligaments, tendons, heart valves, skin, veins, cartilage, and the eye. The sources of tissue banking are the live donor and deceased donors. Additionally, tissue is used in skin replacement, limbal stem cell replacement, bone marrow and immunological replacement, regenerative medicine, and other purposes.
Moreover, Tissue banking is a form of biological insurance where parents bank their baby’s stem cells for future therapies. The main benefits of banking cord tissue are to have different types of cells and more stem cells from the same child. Translational biomedical research has faith in the availability of human tissue to explore disease etiology and prognostic factors, intending to develop better-targeted treatments.
The global tissue banking market size was valued at USD 1318.9 million in 2019 and projected to reach USD 4045.10 million by 2027, growing at a CAGR of 13.56% during the forecast period, 2020-2027. The significant factors are the growing demand for tissue banking, regenerative medicine, bio-banking, and the development of drugs. Moreover, the increasing improvement in tissue banking leads to the rising progress in medical analysis, research laboratories, and pharmaceutical industries with the advancement in storage processes and conditions. Additionally, the increasing diseases such as neurological & cardiovascular disorders, diabetes, cancer, and other diseases will spur the demand for tissue banking in the health care industry. Furthermore, the growing public-private funding for tissue storage activities and the easy maintenance of data through bioinformatics is expected to witness remarkable growth of tissue banking. Moreover, the increasing need for the storage of organs for transplant and the ability to treat debilitating conditions such as heart diseases, Parkinson’s diseases, lung cancer, and injuries to bones and cartilage are expected to propel the demand for tissue banking over the coming years. Furthermore, regulatory norms by the government or FDA for the storage of tissues and approval of new products are fueling the demand for tissue banking in the healthcare market.
Tissue banking is the activity of harvesting, processing, storage, and distribution of transplantable human tissues. Tissues salvage from the human body is used to repair or replace the diseased or lost tissues of the living human body and save many precious lives. Bio-banking of normal tumor cells and stem cells from bone marrow, umbilical cord, and adipose tissue is increasingly used by pathologists and researchers to maintain cell lines and bioengineering. From quality management and legal & regulatory approvals & aspects to clinical grafting, tissue banking became an advanced therapy. Moreover, Private newborn stem cell banks are planning in exploring the application of cord blood in the evolving field of immunotherapies and more than minimally manipulated products due to the massive advantage of cord blood in the treatment of over 80 diseases, including hematologic malignancies and disorders, certain metabolic disorders and congenital immunodeficiency disorders.
Based on the tissue type, the global tissue banking market is segregated into connective tissue, epithelial tissue, muscle tissue, and nervous tissue, including skin, blood, kidney, pancreas, liver, eye, bone, and lymph tissues. The blood tissue segment is estimated to witness the highest growth over the analysis timeframe due to the rise in donations and increasing illnesses such as thalassemia and sickle cell disease and is used to make products such as clotting attributes for people with hemophilia.
The bone tissue will grow significantly due to increasing age-related bone diseases and bone marrow transplants.
The global tissue banking market is divided into equipment, media, and consumables based on the product. Furthermore, the equipment segment is divided into storage systems, freezers, thawing equipment, alarming & coding equipment, and labeling & coding equipment. The equipment segment held a significant market share in 2019 and will gain maximum market revenue by 2027. It is due to associated benefits such as high culture integrity, easy maintenance, and quality control.
The Consumables segment is poised to witness significant growth over the forecast period due to increasing demand for bio-banking products and inventory to secure samples.
The global tissue banking market is divided into cosmetic, research & development, drug discovery, and therapeutic based on the application. The therapeutics segment is to be the highest revenue share for tissue banking during the forecast period. The segment’s revenue is primarily attributed to the involvement of different types of grafting& allografts, cell therapy, and treatment of heart disorders using heart valves.
The drug discovery will witness a lucrative growth rate in the estimated period due to the increasing development of regenerative medicine and new drugs.
The global tissue banking market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is estimated to project considerable growth over 2020-2026. Due to the advent of technology, leading industry players are offering innovative products and increasing donations among medical personnel.
The Asia Pacific will produce a prominent share of the tissue banking market by 2027. Due to the increasing government initiatives and continually improving healthcare infrastructure in the region, mounting healthcare expenditures in up growing countries such as India and China.
Companies such as Atlanta Biologics Inc, BioLife Solutions Inc, BioCision, Cesca Therapeutics, Core Dynamics Ltd, Custom Biogenic Systems, Lifeline Scientific, Sigma-Aldrich Co, Thermo Fisher Scientific Inc, Taylor-Wharton, Panasonic Corporation, QIAGEN, and VWR International LLC are the key players in the global tissue banking market.
By Tissue Type
By Technology
By Application
By Region
Global Tissue Banking Market
Analyst support
After evaluating your requirements and addressing your technical problems, the expert analyst will resolve your query directly.
Customer satisfaction
According to your needs, our expert team will assist you with the capabilities, services, and proper research needs to be required and customize the report accordingly.
Inimitable expertise
Our expert team will create unrivaled reviews to provide you with a deep understanding of the reports.
Assured quality
We have created a systematic way to determine standards and satisfy your expectations.
Instant delivery
Unlike others, we provide you a great deal of instant delivery in the form of PDF/PPT/Word Doc directly to your email address within 24 hours after receiving full payment.
Privacy policy
We understand the inkling of your privacy, we will never misuse your email address.
Custom research service
We are giving you an opportunity through which you can directly ask our expert analyst to customize an exclusive study of the report to serve your research needs.
Quality & accuracy
We provide you with the accurate quality of the customized study of an exclusive report according to your research need.
Data visualization
As the business world’s growing faster every day, we understand the value of data management. We will create the reports by keeping all the visual data sets and metrics in the charts.
Information security
We truly respect your privacy and promise to keep your personal and confidential information safe and secure.